Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2600 (LINC02600) is a human long non-coding RNA (lncRNA) gene, located on chromosome 4 (genomic coordinates: 4:3,758,747-3,763,390, per Ensembl ENSG00000250986 and NCBI Gene 107986251)[3][1][5]. It does not encode a protein and is part of the diverse family of long intergenic non-coding RNAs, which are known to play regulatory roles in gene expression, chromatin structure, and other aspects of cellular biology. To date, there are no literature reports establishing LINC02600 as a therapeutic target (e.g., receptor, enzyme, transporter) or associating it with major biological functions, disease roles, or drug interactions[1][3][5]. Its alternative name, AC141928.1, is used in genome annotations but not in clinical or functional contexts. The current scientific knowledge does not indicate any obvious errors, misspellings, or issues with this gene symbol or accession[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2600 (LINC02600).